Grant: Doctoral: Vanier Canada Graduate Scholarships
University of Toronto
$150,000.00
Identification of molecular drivers and protein mediators of leptomeningeal metastasis in pediatric medulloblastoma for development of novel targeted therapeutics
EF 2019-20
Résumé
Medulloblastoma is the most common type of primary brain tumour in children and a leading cause of pediatric cancer death. Currently, affected children are treated with surgery, chemotherapy, and aggressive radiotherapy, which leaves nearly all patients with lifelong health challenges and cognitive impairment. In a subset of these children, the tumours will spread from the cerebellum (a structure of the brain lying in the posterior base of the skull) where they first arise, and move through the bloodstream to the membranes which cover the brain (the leptomeninges). Once the leptomeninges are colonized, the cancer proliferates rapidly, progressively coating the surface of the brain and ultimately causing death of the affected child. The biological mechanism by which some tumours escape into the bloodstream and spread to the leptomeninges is unclear. Given that the metastatic disease carries mutations which are unique from the original disease in the cerebellum, we hypothesize that there exist specific genes or mutations which facilitate this metastatic process. Further, the very specific dissemination to the leptomeninges (but not other parts of the body) suggests the existence of unique proteins and receptors in the blood vessels in the leptomeninges which enable tumor cells to exist the blood stream uniquely in this location. By identifying the specific genes and cellular processes which drive metastasis, we hope to intelligently develop specific therapies which target these genes or the proteins they encode, and prevent medulloblastoma metastasis in affected children.
Programme
Doctoral: Vanier Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
416173
Name
Van Ommeren Randy
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Cancer Research
Theme2
Biomedical
Prcname2
Vanier Canada Graduate Scholarships CIHR
Projecttitle
Identification of molecular drivers and protein mediators of leptomeningeal metastasis in pediatric medulloblastoma for development of novel targeted therapeutics
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$150,000
Cihrequipment2
$0
Programname2
Doctoral: Vanier Canada Graduate Scholarships
Keyworddelim
Bioinformatics; Cancer; Functional Genomics; Medulloblastoma; Metastasis; Molecular Biology; Neuro-Oncology; Pediatrics; Phage Display; Therapeutics
Abstract
Medulloblastoma is the most common type of primary brain tumour in children and a leading cause of pediatric cancer death. Currently, affected children are treated with surgery, chemotherapy, and aggressive radiotherapy, which leaves nearly all patients with lifelong health challenges and cognitive impairment. In a subset of these children, the tumours will spread from the cerebellum (a structure of the brain lying in the posterior base of the skull) where they first arise, and move through the bloodstream to the membranes which cover the brain (the leptomeninges). Once the leptomeninges are colonized, the cancer proliferates rapidly, progressively coating the surface of the brain and ultimately causing death of the affected child. The biological mechanism by which some tumours escape into the bloodstream and spread to the leptomeninges is unclear. Given that the metastatic disease carries mutations which are unique from the original disease in the cerebellum, we hypothesize that there exist specific genes or mutations which facilitate this metastatic process. Further, the very specific dissemination to the leptomeninges (but not other parts of the body) suggests the existence of unique proteins and receptors in the blood vessels in the leptomeninges which enable tumor cells to exist the blood stream uniquely in this location. By identifying the specific genes and cellular processes which drive metastasis, we hope to intelligently develop specific therapies which target these genes or the proteins they encode, and prevent medulloblastoma metastasis in affected children.
Competitiondate
201911
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Van Ommeren, Randy
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $150,000~ $0~